The effects of Bz+PTX therapy on CCC were also previously explored by our group, supporting reduction in myocarditis and fibrosis, improvement of ECG abnormalities, reduction of TNF, and TNFR1 expression on CD8+ T cells and, more importantly, these effects were sustained after 30 days of treatment suspension [26]. Here, CD8A is linked to myocarditis.